India Global News
Visit iGEN World(opens in a new tab)Explore iGEN Expo(opens in a new tab)
AI Plus
India Global News
Explore Upgrade Plan
Sign InRegister
Breaking
India signs $2B semiconductor deal with Netherlands — ASML to set up training center in BangaloreRBI holds rates steady at 6.5% — Export sector welcomes stability amid global uncertaintyIndia-UAE CEPA crosses $100B trade milestone — Services exports surge 40% YoYEuropean Central Bank signals digital euro interoperability with cross-border trade railsNASA commercial space expo unlocks $12B procurement pipeline for private aerospace corridorsIndia signs $2B semiconductor deal with Netherlands — ASML to set up training center in BangaloreRBI holds rates steady at 6.5% — Export sector welcomes stability amid global uncertaintyIndia-UAE CEPA crosses $100B trade milestone — Services exports surge 40% YoYEuropean Central Bank signals digital euro interoperability with cross-border trade railsNASA commercial space expo unlocks $12B procurement pipeline for private aerospace corridors
Back to News FeedFilm MakingSun Pharma and Mahindra Group Sign Long-Term Supply Pact in Film Making
CompanyS26 · Film MakingFreeSummary

Sun Pharma and Mahindra Group Sign Long-Term Supply Pact in Film Making

A new plant, a new customer agreement and a sharper export focus: Sun Pharma is repositioning its Film Making portfolio for the next cycle.

VM
Vikram MalhotraVERIFIED
Industry Analyst, Manufacturing, IGEN Intelligence
21 Oct 2026, 13:49 IST5 min read2.8K views

Updated 21 Oct 2026, 18:09 IST

Film Making: illustrative image for "Sun Pharma and Mahindra Group Sign Long-Term Supply Pact in Film Making"
Business leaders and the boardroom: illustrative image for Film Making coverage. Photo: Unsplash.
238
3
Sponsored

Trade finance for exporters: invoice discounting in 48 hours (partner content).

Sun Pharma reported consolidated revenue growth of 8.9% for Q4 FY27, led by its Film Making division, which contributed 14.9% of the total. Operating margin held at 8.6%, a few basis points below the previous quarter as higher logistics and wage costs offset operating leverage.

Balance-sheet metrics remain comfortable. Net debt to earnings stood at 0.8 times, and the company retired $47 million of high-cost borrowings during the quarter. Credit analysts say the improvement leaves room to fund the expansion without equity dilution.

Key takeaways

  • Long-term supply pact with Mahindra Group anchors part of the expansion.
  • Revenue grew 8.9% in Q4 FY27; Film Making contributed 14.9% of the total.
  • Management flags input costs and clearance timing as key risks.
  • Capex guidance raised to $6.4 billion from $47 million.
  • New facility near Cochin adds 826 tonnes of capacity and about 1,200 jobs.

The numbers

Employees and communities are part of the plan: a skills academy near the new site will train 2,000 technicians over three years, funded jointly with the state government. Management said local hiring is a condition of the incentives it has received.

Export performance was a bright spot. Shipments to Saudi Arabia rose 8.9%, helped by certification wins and shorter lead times from Cochin. Management said it would deepen its presence in the market by adding a local warehouse and a technical service team.

By the numbers

Revenue growth
+16%
YoY
consolidated revenue
Order book
$1.7B
14 months
order book
Operating margin
15.6%
-0.2 pts
operating margin
Net debt/EBITDA
0.6x
comfortable
net debt to EBITDA

Environmental, social and governance targets also featured. The company reiterated its goal to reduce emissions intensity by a third by 2029, and disclosed that 14.9% of electricity at its main sites now comes from renewable sources under long-term contracts.

“The pact is not just volume; it is a joint roadmap for higher-value products.”

Lakshmi Venkatesan, Agri & Food Trade Reporter

Expansion and capital allocation

Risks were not ignored. Executives flagged input-cost volatility, potential delays in environmental clearances for the new plant and the possibility of tougher competition from lower-priced imports. They said a pricing-pass-through mechanism covers about 60 percent of exposure.

Sun Pharma quarterly revenue$ million
Sun Pharma quarterly revenueSun Pharma quarterly revenue: from 39.3 $ million in Q1 FY26 to 47.7 $ million in Q2 FY27; high 47.7 in Q2 FY27, low 39.3 in Q1 FY26.011.923.935.847.739.3Q1 FY2639.8Q2 FY2641.4Q3 FY2644.8Q4 FY2645.7Q1 FY2747.7Q2 FY27

Source: IGEN Intelligence analysis of central board of indirect taxes & customs data. Illustrative mock data.

A new long-term agreement with Mahindra Group anchors a portion of the expansion. The deal covers multi-year supply at index-linked pricing, with volume commitments that provide a floor, and includes a joint development programme for higher-specification products with better margins.

Segment performance for the quarter
SegmentRevenueYoYMargin
Film Making (core)$208M+13.5%23.8%
Exports$361M-2.6%9.2%
Domestic retail$200M+11.6%20.8%
Services$71M+3.8%10.7%
Other$207M+8.7%21.4%
Source: Industry association surveys; IGEN estimates. Figures are illustrative mock data.

Customers, contracts and exports

Capital expenditure guidance was raised to $6.4 billion for the fiscal year, from $47 million previously. Management said the increase reflects accelerated spending on automation and on debottlenecking existing lines, which it expects to deliver 8.6% more output without additional land.

Timeline of key events

  1. 19 Sep 2026
    Results announced

    Revenue up 8.9%; margin steady at 8.6%.

  2. 27 Sep 2026
    Capex raised

    Guidance moves to $6.4 billion to fund automation and debottlenecking.

  3. 5 Oct 2026
    Supply pact signed

    Multi-year agreement with Mahindra Group at index-linked pricing.

  4. 13 Oct 2026
    Groundbreaking

    Construction at the new facility near Cochin begins.

  5. 21 Oct 2026
    First production

    Targeted within 20 months of groundbreaking.

The company also announced a new facility near Cochin, designed to add about 826 tonnes of annual capacity and create roughly 1,200 jobs. Construction begins next quarter, and first production is targeted within 20 months. The plant will be built to meet European environmental standards.

Expert commentary

“Visibility is worth more than growth. We can plan investments when we can see 14 months ahead.”

RD
Rohan Deshpande
Markets Editor, IGEN News

“For Film Making, the margin of safety is in diversification: two markets, two gateways and two sources of finance.”

LV
Lakshmi Venkatesan
Agri & Food Trade Reporter, IGEN News

“In my conversations with procurement heads, reliability is mentioned three times for every mention of price.”

TW
Dr. Tomas Weber
Senior Fellow, Berlin Institute for Trade

Risks and analyst view

On the post-results call, management said the order book now stands at $6.4 billion, equivalent to roughly 14 months of revenue, with about a third from export customers in Saudi Arabia and Brazil. The chief financial officer described visibility as the best in five years.

What it means for you

Investors

Order visibility and a manageable balance sheet support the story; track execution on the new plant and margin pass-through.

Suppliers

Expansion will lift procurement; engage early on qualification for the new lines.

Customers

Longer-term agreements offer price stability in exchange for volume commitments; compare index-linked terms carefully.

Job seekers

About 1,200 direct roles and a technician academy are planned near Cochin; applications open with the state skills portal.

Companies and leaders in this story

Sun Pharma Dr. Reddy's Laboratories Bharat Forge Mahindra Group Rohini Sethi Rakesh Bhargava

Frequently asked questions

Mainly volume in the Film Making division and higher export realisations, partly offset by pricing pressure in domestic segments.

Sources

  1. Central Board of Indirect Taxes & Customs: Port-level clearance and dwell data
  2. Industry association surveys: Member-level compliance and sentiment data
  3. Company filings and earnings calls: Disclosures on order books and capex
  4. Directorate General of Foreign Trade: Export-import policy and public notices

Mock content for demonstration. Names, figures and quotes are illustrative and not real reporting.

#FilmMaking#Company#Earnings#Expansion#Capex#SaudiArabia
VM
Written by

Vikram Malhotra

Industry Analyst, Manufacturing, IGEN Intelligence

Writes on capital goods, automotive supply chains and the production-linked incentive landscape.

Source & Editorial Attribution

Ministry of Information & Broadcasting · IGEN Trade Intelligence

This article is curated and summarized by the IGEN editorial desk. All text is verified from official filings and trade bulletins, rendered strictly in plain text for compliance and clarity. Full text and regulatory updates are archived in the national registry.

Daily briefing

Get stories like this in your inbox

One concise email each morning on trade, policy and markets across Film Making and 49 other sectors.

Discussion (3)

Sort by: Most recent
Log in to comment
T
Tanvi Joshi
38m ago

Good to see concrete figures instead of generalities. The table on destination markets is especially helpful.

D
Deepa Nair
2h ago

Any word on how this plays out for services exporters? Would be a good follow-up.

R
Rahul Menon
5h ago

The timeline section is a handy reference. Sharing with our procurement team.

In this article
  1. 1. The numbers
  2. 2. Expansion and capital allocation
  3. 3. Customers, contracts and exports
  4. 4. Risks and analyst view
  5. 5. Discussion (3)

Trending now

  1. 01Asian Paints and Sun Pharma Sign Long-Term Supply Pact in Heavy Industries
  2. 02Carbon, Cost and Customers: How Food Processing Industries Is Decarbonising Faster Than Expected
  3. 03AI Meets Startups: Early Adopters Report 13.5% Productivity Gains
  4. 04The Amit Chandra Interview: Why Banking Needs a Ten-Year View
  5. 05New Gaming Incentive Scheme Clears Cabinet With $1.8 billion Outlay
Topic
S26 · Film Making

Ministry of Information & Broadcasting

Saudi ArabiaBrazil

More to read

All headlines →
Company · Heavy Industries

Asian Paints and Sun Pharma Sign Long-Term Supply Pact in Heavy Industries

7 min read
Sector · Food Processing Industries

Carbon, Cost and Customers: How Food Processing Industries Is Decarbonising Faster Than Expected

8 min read
Sector · Startups

AI Meets Startups: Early Adopters Report 13.5% Productivity Gains

9 min read
Leader · Banking

The Amit Chandra Interview: Why Banking Needs a Ten-Year View

9 min read
Policy · Gaming

New Gaming Incentive Scheme Clears Cabinet With $1.8 billion Outlay

6 min read
Company · Film Making

Mahindra Group Commits $4.7 billion to Film Making Expansion as Global Customers Seek a Second Source

4 min read
India Global News

The premier institutional platform for global trade intelligence. Empowering 50,000+ professionals with real-time insights, bilateral trade corridors, and predictive analytics across 195 countries.

Stay Ahead of the Curve

Get daily trade intelligence briefings delivered to your inbox. Join 50k+ leaders. Delivered fresh before market opening.

Secure subscription. No spam. Strict data privacy.

Platform

  • Headlines
  • Trending
  • Company News
  • Leader News
  • Expert News
  • Sector News
  • Country News
  • Communities

Intelligence

  • Executive Decision Signals
  • Trade Policy Tracker
  • Bilateral Corridor Matrix
  • Live FDI & Capital Tracker
  • 60 Industrial Sectors
  • Predictive Signals

Events & Expo

  • Expert AMAs & Webinars
  • Executive Roundtables
  • Global Trade Summits
  • B2B Expo Network

Company

  • About iGEN
  • Membership Plans
  • Corporate Directory
  • CareersHiring
  • Contact
  • Advertise

Get In Touch

  • +91 11 4567 8900
  • contact@indiaglobalnews.org
  • New Delhi, India

© 2026 India Global News. All rights reserved.

iGEN is a registered trademark of Global Trade Intelligence Corp.

  • Privacy Policy
  • Terms of Service
  • Cookie Policy
  • Sitemap
System Operational
FeedCountryLeaderSearchProfile
📱Feed
🔥Headlines
📈Trending
🏢Company News
👑Leader News
🎓Expert News
🏭Sector News
🌐Country News
🤝Communities
👤My News
Back to News FeedFilm MakingSun Pharma and Mahindra Group Sign Long-Term Supply Pact in Film Making
CompanyS26 · Film MakingFreeSummary

Sun Pharma and Mahindra Group Sign Long-Term Supply Pact in Film Making

A new plant, a new customer agreement and a sharper export focus: Sun Pharma is repositioning its Film Making portfolio for the next cycle.

VM
Vikram MalhotraVERIFIED
Industry Analyst, Manufacturing, IGEN Intelligence
21 Oct 2026, 13:49 IST5 min read2.8K views

Updated 21 Oct 2026, 18:09 IST

Film Making: illustrative image for "Sun Pharma and Mahindra Group Sign Long-Term Supply Pact in Film Making"
Business leaders and the boardroom: illustrative image for Film Making coverage. Photo: Unsplash.
238
3
Sponsored

Trade finance for exporters: invoice discounting in 48 hours (partner content).

Sun Pharma reported consolidated revenue growth of 8.9% for Q4 FY27, led by its Film Making division, which contributed 14.9% of the total. Operating margin held at 8.6%, a few basis points below the previous quarter as higher logistics and wage costs offset operating leverage.

Balance-sheet metrics remain comfortable. Net debt to earnings stood at 0.8 times, and the company retired $47 million of high-cost borrowings during the quarter. Credit analysts say the improvement leaves room to fund the expansion without equity dilution.

Key takeaways

  • Long-term supply pact with Mahindra Group anchors part of the expansion.
  • Revenue grew 8.9% in Q4 FY27; Film Making contributed 14.9% of the total.
  • Management flags input costs and clearance timing as key risks.
  • Capex guidance raised to $6.4 billion from $47 million.
  • New facility near Cochin adds 826 tonnes of capacity and about 1,200 jobs.

The numbers

Employees and communities are part of the plan: a skills academy near the new site will train 2,000 technicians over three years, funded jointly with the state government. Management said local hiring is a condition of the incentives it has received.

Export performance was a bright spot. Shipments to Saudi Arabia rose 8.9%, helped by certification wins and shorter lead times from Cochin. Management said it would deepen its presence in the market by adding a local warehouse and a technical service team.

By the numbers

Revenue growth
+16%
YoY
consolidated revenue
Order book
$1.7B
14 months
order book
Operating margin
15.6%
-0.2 pts
operating margin
Net debt/EBITDA
0.6x
comfortable
net debt to EBITDA

Environmental, social and governance targets also featured. The company reiterated its goal to reduce emissions intensity by a third by 2029, and disclosed that 14.9% of electricity at its main sites now comes from renewable sources under long-term contracts.

“The pact is not just volume; it is a joint roadmap for higher-value products.”

Lakshmi Venkatesan, Agri & Food Trade Reporter

Expansion and capital allocation

Risks were not ignored. Executives flagged input-cost volatility, potential delays in environmental clearances for the new plant and the possibility of tougher competition from lower-priced imports. They said a pricing-pass-through mechanism covers about 60 percent of exposure.

Sun Pharma quarterly revenue$ million
Sun Pharma quarterly revenueSun Pharma quarterly revenue: from 39.3 $ million in Q1 FY26 to 47.7 $ million in Q2 FY27; high 47.7 in Q2 FY27, low 39.3 in Q1 FY26.011.923.935.847.739.3Q1 FY2639.8Q2 FY2641.4Q3 FY2644.8Q4 FY2645.7Q1 FY2747.7Q2 FY27

Source: IGEN Intelligence analysis of central board of indirect taxes & customs data. Illustrative mock data.

A new long-term agreement with Mahindra Group anchors a portion of the expansion. The deal covers multi-year supply at index-linked pricing, with volume commitments that provide a floor, and includes a joint development programme for higher-specification products with better margins.

Segment performance for the quarter
SegmentRevenueYoYMargin
Film Making (core)$208M+13.5%23.8%
Exports$361M-2.6%9.2%
Domestic retail$200M+11.6%20.8%
Services$71M+3.8%10.7%
Other$207M+8.7%21.4%
Source: Industry association surveys; IGEN estimates. Figures are illustrative mock data.

Customers, contracts and exports

Capital expenditure guidance was raised to $6.4 billion for the fiscal year, from $47 million previously. Management said the increase reflects accelerated spending on automation and on debottlenecking existing lines, which it expects to deliver 8.6% more output without additional land.

Timeline of key events

  1. 19 Sep 2026
    Results announced

    Revenue up 8.9%; margin steady at 8.6%.

  2. 27 Sep 2026
    Capex raised

    Guidance moves to $6.4 billion to fund automation and debottlenecking.

  3. 5 Oct 2026
    Supply pact signed

    Multi-year agreement with Mahindra Group at index-linked pricing.

  4. 13 Oct 2026
    Groundbreaking

    Construction at the new facility near Cochin begins.

  5. 21 Oct 2026
    First production

    Targeted within 20 months of groundbreaking.

The company also announced a new facility near Cochin, designed to add about 826 tonnes of annual capacity and create roughly 1,200 jobs. Construction begins next quarter, and first production is targeted within 20 months. The plant will be built to meet European environmental standards.

Expert commentary

“Visibility is worth more than growth. We can plan investments when we can see 14 months ahead.”

RD
Rohan Deshpande
Markets Editor, IGEN News

“For Film Making, the margin of safety is in diversification: two markets, two gateways and two sources of finance.”

LV
Lakshmi Venkatesan
Agri & Food Trade Reporter, IGEN News

“In my conversations with procurement heads, reliability is mentioned three times for every mention of price.”

TW
Dr. Tomas Weber
Senior Fellow, Berlin Institute for Trade

Risks and analyst view

On the post-results call, management said the order book now stands at $6.4 billion, equivalent to roughly 14 months of revenue, with about a third from export customers in Saudi Arabia and Brazil. The chief financial officer described visibility as the best in five years.

What it means for you

Investors

Order visibility and a manageable balance sheet support the story; track execution on the new plant and margin pass-through.

Suppliers

Expansion will lift procurement; engage early on qualification for the new lines.

Customers

Longer-term agreements offer price stability in exchange for volume commitments; compare index-linked terms carefully.

Job seekers

About 1,200 direct roles and a technician academy are planned near Cochin; applications open with the state skills portal.

Companies and leaders in this story

Sun Pharma Dr. Reddy's Laboratories Bharat Forge Mahindra Group Rohini Sethi Rakesh Bhargava

Frequently asked questions

Mainly volume in the Film Making division and higher export realisations, partly offset by pricing pressure in domestic segments.

Sources

  1. Central Board of Indirect Taxes & Customs: Port-level clearance and dwell data
  2. Industry association surveys: Member-level compliance and sentiment data
  3. Company filings and earnings calls: Disclosures on order books and capex
  4. Directorate General of Foreign Trade: Export-import policy and public notices

Mock content for demonstration. Names, figures and quotes are illustrative and not real reporting.

#FilmMaking#Company#Earnings#Expansion#Capex#SaudiArabia
VM
Written by

Vikram Malhotra

Industry Analyst, Manufacturing, IGEN Intelligence

Writes on capital goods, automotive supply chains and the production-linked incentive landscape.

Source & Editorial Attribution

Ministry of Information & Broadcasting · IGEN Trade Intelligence

This article is curated and summarized by the IGEN editorial desk. All text is verified from official filings and trade bulletins, rendered strictly in plain text for compliance and clarity. Full text and regulatory updates are archived in the national registry.

Daily briefing

Get stories like this in your inbox

One concise email each morning on trade, policy and markets across Film Making and 49 other sectors.

Discussion (3)

Sort by: Most recent
Log in to comment
T
Tanvi Joshi
38m ago

Good to see concrete figures instead of generalities. The table on destination markets is especially helpful.

D
Deepa Nair
2h ago

Any word on how this plays out for services exporters? Would be a good follow-up.

R
Rahul Menon
5h ago

The timeline section is a handy reference. Sharing with our procurement team.

In this article
  1. 1. The numbers
  2. 2. Expansion and capital allocation
  3. 3. Customers, contracts and exports
  4. 4. Risks and analyst view
  5. 5. Discussion (3)

Trending now

  1. 01Asian Paints and Sun Pharma Sign Long-Term Supply Pact in Heavy Industries
  2. 02Carbon, Cost and Customers: How Food Processing Industries Is Decarbonising Faster Than Expected
  3. 03AI Meets Startups: Early Adopters Report 13.5% Productivity Gains
  4. 04The Amit Chandra Interview: Why Banking Needs a Ten-Year View
  5. 05New Gaming Incentive Scheme Clears Cabinet With $1.8 billion Outlay
Topic
S26 · Film Making

Ministry of Information & Broadcasting

Saudi ArabiaBrazil

More to read

All headlines →
Company · Heavy Industries

Asian Paints and Sun Pharma Sign Long-Term Supply Pact in Heavy Industries

7 min read
Sector · Food Processing Industries

Carbon, Cost and Customers: How Food Processing Industries Is Decarbonising Faster Than Expected

8 min read
Sector · Startups

AI Meets Startups: Early Adopters Report 13.5% Productivity Gains

9 min read
Leader · Banking

The Amit Chandra Interview: Why Banking Needs a Ten-Year View

9 min read
Policy · Gaming

New Gaming Incentive Scheme Clears Cabinet With $1.8 billion Outlay

6 min read
Company · Film Making

Mahindra Group Commits $4.7 billion to Film Making Expansion as Global Customers Seek a Second Source

4 min read